Buspirone Dosing Schedule
Start buspirone at 5 mg twice daily and increase by 5 mg per day every 2-3 days as tolerated, with a typical target dose of 15-30 mg per day divided into 2-3 doses, and a maximum of 60 mg per day (20 mg three times daily). 1, 2
Standard Dosing Protocol
Initial Dosing
Titration Schedule
- Increase by 5 mg per day every 2-3 days as tolerated
- The FDA label supports gradual dose escalation to minimize adverse effects 2
- Research demonstrates that slower titration improves tolerability, particularly in reducing dizziness and nausea 3, 4
Target Maintenance Dose
- Typical effective range: 15-30 mg per day in divided doses 1
- Can be given as either:
- Studies show equivalent efficacy and safety between BID and TID regimens at 30 mg/day total 3, 4
Maximum Dose
- Maximum: 60 mg per day (20 mg three times daily) 1, 2
- Higher doses (up to 45 mg/day) have been studied in generalized anxiety disorder with coexisting depressive symptoms 5
Special Populations
Pediatric Dosing (Ages 6-17)
- Studied doses: 7.5-30 mg BID (15-60 mg/day) 2
- Pharmacokinetic data show higher plasma concentrations in children compared to adults at identical doses 6
- Young children (2-6 years) with autism: 2.5 mg BID showed efficacy for repetitive behaviors; 5 mg BID showed no benefit 7
Geriatric Patients
- Start at lower doses with slower titration 2
- No specific dose adjustment required based on age alone, but greater sensitivity possible 2
Renal Impairment
- Severe renal impairment: Cannot be recommended due to increased plasma levels and prolonged half-life 2
- Use with caution in mild-moderate impairment
Hepatic Impairment
- Severe hepatic impairment: Cannot be recommended 2
- Use with extreme caution in any degree of hepatic dysfunction
Critical Timing Considerations
Onset of Action
- Therapeutic effect requires 2-4 weeks to become fully effective 1
- This delayed onset is crucial for patient counseling to prevent premature discontinuation
- Unlike benzodiazepines, buspirone does not provide immediate anxiolytic effects
Duration of Adequate Trial
- Minimum 4-6 weeks at target dose before assessing efficacy
- If inadequate response after adequate trial, consider dose escalation toward maximum
Common Pitfalls to Avoid
- Expecting immediate anxiolytic effects: Patients must understand the 2-4 week delay in therapeutic benefit
- Inadequate dose titration: Rapid escalation increases dizziness, nausea, and lightheadedness 6, 3
- Premature discontinuation: Many patients stop before reaching therapeutic effect due to delayed onset
- Use in severe hepatic/renal disease: Contraindicated due to significantly altered pharmacokinetics 2
- Combining with MAO inhibitors: Contraindicated due to risk of hypertensive reactions
- Abrupt discontinuation: Should taper gradually, though physical dependence is minimal 2
Dosing Flexibility
BID vs TID regimens are equally effective - the choice between 15 mg BID versus 10 mg TID at 30 mg/day total can be based on patient convenience and compliance 3, 4. The BID regimen may offer better adherence without compromising efficacy or safety.